Biology & Look-Alikes: Understanding the Science

Understanding why the body is growing differently requires looking deep into how cells communicate. In Segmental Progressive Overgrowth with Fibroadipose Hyperplasia, the root cause is a “glitch” in a specific biological pathway that tells cells when to grow and when to stop ^[1].

The ‘Always On’ Growth Switch

All cells in the body use a communication system called the PI3K/AKT/mTOR signaling pathway ^[1]. Think of this pathway like a series of switches in a circuit that controls a lightbulb. When the body needs more tissue—such as during normal childhood growth—the switches flip “on” to allow cells to multiply and grow larger ^[2].

In PROS, a mutation in the PIK3CA gene has essentially taped one of those switches in the “on” position ^[3].

• PIK3CA: This gene provides instructions for making part of the PI3K enzyme.
• The Overstimulation: Because the switch is stuck, the pathway sends a constant, loud signal to the cells to “grow, survive, and build more tissue” ^[1].
• The Result: This leads to an over-accumulation of fat (adipose tissue) and tough connective tissue (fibrous tissue), causing the physical overgrowth you see ^[4].

Because this mutation is mosaic (meaning it only happened in some cells during early development), only the areas of the body that descended from those original mutated cells will show this overgrowth ^[5].

Sorting Through the Look-Alikes

Because several rare conditions cause overgrowth, doctors must work carefully to distinguish PROS from “look-alike” syndromes. Getting this right is crucial because the treatments for one condition may not work for another ^[6].

Proteus Syndrome

For a long time, many patients with PROS were mistakenly diagnosed with Proteus Syndrome. While they look similar, they have different genetic drivers:

• PROS: Caused by a mutation in the PIK3CA gene ^[1].
• Proteus Syndrome: Caused by a mutation in the AKT1 gene ^[7].
• The Difference: Proteus syndrome is often characterized by “disproportionate” growth that may not be obvious at birth but becomes very aggressive in early childhood. It also frequently features a specific type of thickened skin on the soles of the feet called a cerebriform connective-tissue nevus ^[8].

Parkes-Weber Syndrome and Fast-Flow Lesions

Another condition that can look like PROS is Parkes-Weber Syndrome. One way doctors tell them apart is by evaluating blood flow:

• PROS (Slow-Flow): Most vascular malformations in PROS are “slow-flow,” meaning the blood or lymph fluid moves slowly through abnormally formed veins or lymphatic vessels ^[9].
• Parkes-Weber (Fast-Flow): This is a “fast-flow” condition where blood shunts directly from arteries to veins through abnormal connections called arteriovenous fistulas ^[10].
• The Difference: Parkes-Weber/CM-AVM phenotypes are typically associated with the RASA1 gene, while EPHB4 more commonly causes CM-AVM type 2 and Parkes-Weber-like presentations ^[11]. Identifying “fast-flow” is vital because it requires different surgical and interventional approaches ^[12]. A fast-flow lesion should prompt evaluation for an alternate or coexisting vascular-malformation disorder, but does not by itself rule out PROS.

Klippel-Trenaunay Syndrome (KTS)

You may have heard the term Klippel-Trenaunay Syndrome or KTS. Historically, this was treated as a completely separate diagnosis. However, medical experts now recognize that KTS is a clinical phenotype in which PIK3CA variants are found in many affected-tissue samples, rather than a diagnosis that is automatically molecularly confirmed ^[13][14]. Today, KTS is generally considered a specific presentation within the broader PROS umbrella ^[9].

Why the Specific Label Matters

Precise testing—often involving testing the affected tissue rather than just blood—helps determine which “switch” is stuck ^[15]. Knowing the exact biology involved allows your medical team to predict risks and discuss the most advanced, targeted care options for the specific presentation ^[1][16].